Clozapine placental passage at delivery: an update
Introduction Clozapine is an effective second-generation antipsychotic that is approved for treatment-resistant schizophrenia and risk reduction of recurrent suicidal behavior in schizophrenia or schizoaffective disorder. Its available pregnancy pharmacikinetics data remain limited, which presents...
Main Authors: | M.L. Imaz, S. Lera, E. Roda, A. Roca, A. Torres, E. Solé, S. Andres, A. Mallorquí, L. Garcia-Esteve |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822006101/type/journal_article |
Similar Items
-
Lithium placental passage at delivery: an observational study
by: M.L. Imaz, et al.
Published: (2022-06-01) -
Neonatal and infant outcomes of clozapine exposure in pregnancy: A consecutive case series
by: M.L. Imaz, et al.
Published: (2021-04-01) -
Clozapine Use During Pregnancy and Lactation: A Case-Series Report
by: M. Luisa Imaz, et al.
Published: (2018-03-01) -
Lithium placental passage at delivery and neonatal outcomes: A retrospective observational study
by: M.L. Imaz, et al.
Published: (2021-04-01) -
Clozapine-induced myocarditis: a case report and literature review
by: I. Angélico Ferreira, et al.
Published: (2022-06-01)